Anti-Human CD262 Recombinant Antibody(Tigatuzumab)
- 
									
产品编号
YR1151
 - 
									
别名
科研级 Tigatuzumab ( 替加组单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Tigatuzumab
 - 
									
规格
- 1mg
 - 5mg
 
 
| Catalog Number | YR1151 | 
| Alias | 科研级 Tigatuzumab ( 替加组单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Tigatuzumab | 
| Size | 1mg, 5mg | 
| Molecular Name | Tigatuzumab | 
| CAS Number | 918127-53-4 | 
| Target | CD262[Homo sapiens] | 
| Antibody Isotype | IgG1 | 
| Clonity | Monoclonal | 
| Concentration | 1mg/ml | 
| Purity | >95% as determined by SDS-PAGE | 
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | Shipped on ice packs. | 
| Background | Tigatuzumab (CS-1008) is a monoclonal antibod for the treatment of cancer. As of October 2009, a clinical trial for the treatment of pancreatic cancer, Phase II trials for colorectal cancer, non-small cell lung cancer, and ovarian cancer have been completed. | 
| Application | IF, IP, Neut, FuncS, ELISA, FCM | 
| Remarks | This product is for research use only. | 
							
							
							
							
						
								0